Shares of Healthcare Trust of America, Inc. (NYSE:HTA) have been given an average recommendation of “Buy” by the fourteen research firms that are presently covering the stock, MarketBeat.com reports. Four research analysts have rated the stock with a hold recommendation, seven have issued a buy recommendation and two have given a strong buy recommendation to the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is $34.00.

A number of equities analysts recently weighed in on HTA shares. BidaskClub downgraded shares of Healthcare Trust of America from a “strong-buy” rating to a “buy” rating in a report on Saturday, July 8th. Mizuho reissued a “buy” rating on shares of Healthcare Trust of America in a report on Tuesday, June 27th. Stifel Nicolaus cut their price target on shares of Healthcare Trust of America from $36.00 to $34.00 and set a “buy” rating on the stock in a report on Wednesday, July 12th. BMO Capital Markets reissued a “buy” rating and issued a $35.00 price target on shares of Healthcare Trust of America in a report on Monday, October 2nd. Finally, Jefferies Group LLC reissued a “buy” rating and issued a $34.00 price target on shares of Healthcare Trust of America in a report on Tuesday, October 3rd.

TRADEMARK VIOLATION NOTICE: This report was reported by American Banking News and is owned by of American Banking News. If you are viewing this report on another site, it was copied illegally and republished in violation of United States and international copyright legislation. The legal version of this report can be viewed at https://www.americanbankingnews.com/2017/10/12/healthcare-trust-of-america-inc-hta-given-average-rating-of-buy-by-analysts-2.html.

Shares of Healthcare Trust of America (NYSE:HTA) traded up 0.81% during trading on Thursday, reaching $29.98. 1,632,863 shares of the company’s stock were exchanged. The company has a 50 day moving average price of $30.47 and a 200-day moving average price of $30.90. Healthcare Trust of America has a 52-week low of $26.34 and a 52-week high of $33.00. The company has a market capitalization of $6.02 billion, a PE ratio of 146.96 and a beta of 0.30.

Healthcare Trust of America (NYSE:HTA) last issued its quarterly earnings results on Monday, July 31st. The real estate investment trust reported $0.39 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.39. The company had revenue of $139.90 million for the quarter, compared to the consensus estimate of $133.69 million. Healthcare Trust of America had a net margin of 6.07% and a return on equity of 1.42%. The firm’s quarterly revenue was up 23.6% on a year-over-year basis. During the same period in the previous year, the firm earned $0.38 EPS. On average, equities analysts forecast that Healthcare Trust of America will post $0.25 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Friday, October 6th. Shareholders of record on Monday, October 2nd were issued a dividend of $0.305 per share. The ex-dividend date was Friday, September 29th. This is an increase from Healthcare Trust of America’s previous quarterly dividend of $0.30. This represents a $1.22 annualized dividend and a yield of 4.07%. Healthcare Trust of America’s dividend payout ratio is 580.95%.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Westpac Banking Corp purchased a new stake in Healthcare Trust of America during the second quarter valued at about $7,499,000. Legal & General Group Plc lifted its holdings in Healthcare Trust of America by 39.9% during the second quarter. Legal & General Group Plc now owns 532,683 shares of the real estate investment trust’s stock valued at $16,572,000 after purchasing an additional 151,890 shares during the last quarter. US Bancorp DE lifted its holdings in Healthcare Trust of America by 1,142.9% during the second quarter. US Bancorp DE now owns 4,350 shares of the real estate investment trust’s stock valued at $135,000 after purchasing an additional 4,000 shares during the last quarter. JPMorgan Chase & Co. lifted its holdings in Healthcare Trust of America by 5,675.3% during the second quarter. JPMorgan Chase & Co. now owns 6,025,724 shares of the real estate investment trust’s stock valued at $187,461,000 after purchasing an additional 5,921,387 shares during the last quarter. Finally, Schwab Charles Investment Management Inc. lifted its holdings in Healthcare Trust of America by 15.1% during the first quarter. Schwab Charles Investment Management Inc. now owns 678,084 shares of the real estate investment trust’s stock valued at $21,333,000 after purchasing an additional 88,903 shares during the last quarter. 97.75% of the stock is currently owned by institutional investors and hedge funds.

About Healthcare Trust of America

Healthcare Trust of America, Inc is a real estate investment trust. The Company is an owner and operator of medical office buildings (MOBs) in the United States. The Company focuses on owning and operating MOBs that serve healthcare delivery and are located on health system campuses, near university medical centers, or in community core outpatient locations.

Analyst Recommendations for Healthcare Trust of America (NYSE:HTA)

Receive News & Ratings for Healthcare Trust of America Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Trust of America Inc. and related companies with MarketBeat.com's FREE daily email newsletter.